EMPO yields 500000.00% · JNJ yields 2.13%● Live data
📍 EMPO pulled ahead of the other in Year 1
Combined, EMPO + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EMPO + JNJ for your $10,000?
Empowered Products, Inc., together with its subsidiaries, manufactures, sells, and distributes personal care products principally in the United States, Europe, and Asia. It provides various products, including topical gels, lotions, and oils, which are designed to enhance a person's mental focus and to improve the bond of interpersonal relationships. The company sells 12 formulated skin lubricants under PINK for women and GUN OIL for men trademarks. It offers various products for men, such as GUN OIL Silicone, a silicone-based interactive lubricant; GUN OIL H2O, a water-based interactive lubricant; GUN OIL Force Recon, a combination water and silicone interactive lubricant; GUN OIL Gel, a gelatinous lubricant for men's personal toys; GUN OIL Stroke 29, a self-applied men's personal lubricant; GUN OIL Loaded, a silicone infused cream hybrid interactive lubricant; GUN OIL Jack Jelly, a self-applied men's personal lubricant in gelatinous form; and GUN OIL Shine, a personal toy cleaner. The company also provides products for women comprising PINK Silicone, an interactive lubricant with silicone vitamin E and aloe vera; PINK Water, a water-based interactive lubricant with vitamin E and aloe vera; Hot PINK, an exothermic massage lubricant; PINK Frolic, a women's personal toy lubricant; PINK Unity, a gelatinous hybrid lubricant with silicone and water; PINK Indulgence Crème, a hybrid cream interactive lubricant; and PINK Sparkle, a personal toy cleaner. Empowered Products, Inc. sells its products directly to retailers, as well as to consumers through its online Wellness Stores. The company is headquartered in Las Vegas, Nevada.
Full EMPO Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.